Immediate Impact

2 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2024 Standout
2 intermediate papers

Works of Xuehui Chu being referenced

Chronic intermittent hypoxia contributes to non-alcoholic steatohepatitis progression in patients with obesity
2022
Prolactin improves hepatic steatosis via CD36 pathway
2018

Author Peers

Author Last Decade Papers Cites
Xuehui Chu 303 194 89 244 35 750
Mei‐Hsiu Chen 319 115 84 98 40 830
MD Menger 374 53 40 176 27 948
Xiaolei Shi 532 519 30 153 48 973
Adriana Bastos Carvalho 274 135 48 68 46 871
Yitao Ding 306 165 12 196 44 943
Nerea García‐Urkía 273 35 54 121 23 663
Lingjie Li 112 69 18 190 43 804
Wenyi Chen 202 67 33 86 49 887
Elisa Montanari 246 108 42 77 24 885
Claude Rescan 341 234 124 72 16 822

All Works

Loading papers...

Rankless by CCL
2026